🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/07/2008 | 35,57 | 36,58 | 33,18 | 33,71 | -6,24% | 9,58% | 59.019.378 |
| 18/07/2008 | 35,42 | 35,96 | 34,92 | 35,95 | +1,95% | 2,94% | 19.737.508 |
| 17/07/2008 | 34,87 | 35,27 | 34,39 | 35,27 | +0,90% | 2,52% | 17.984.099 |
| 16/07/2008 | 34,69 | 35,31 | 34,54 | 34,95 | +0,14% | 2,20% | 19.624.114 |
| 15/07/2008 | 34,95 | 35,44 | 34,68 | 34,90 | -0,79% | 2,18% | 19.261.087 |
| 14/07/2008 | 35,12 | 35,65 | 34,99 | 35,18 | +0,33% | 1,87% | 10.522.549 |
| 11/07/2008 | 34,97 | 35,30 | 34,44 | 35,07 | -0,68% | 2,46% | 15.066.048 |
| 10/07/2008 | 35,44 | 36,02 | 34,66 | 35,31 | -0,16% | 3,85% | 16.704.910 |
| 09/07/2008 | 35,40 | 36,15 | 35,27 | 35,36 | +0,24% | 2,51% | 21.444.490 |
| 08/07/2008 | 35,07 | 35,72 | 35,06 | 35,28 | +1,01% | 1,88% | 26.804.382 |
| 07/07/2008 | 35,87 | 36,25 | 34,55 | 34,92 | -4,81% | 4,74% | 34.836.358 |
| 03/07/2008 | 36,53 | 36,93 | 36,53 | 36,69 | +1,08% | 1,10% | 11.196.727 |
| 02/07/2008 | 37,09 | 37,12 | 36,21 | 36,30 | -0,83% | 2,44% | 18.647.483 |
| 01/07/2008 | 35,70 | 36,96 | 35,63 | 36,60 | +1,78% | 3,72% | 24.465.350 |
| 30/06/2008 | 35,29 | 36,39 | 35,29 | 35,96 | +1,92% | 3,14% | 22.680.606 |
| 27/06/2008 | 34,65 | 36,15 | 34,59 | 35,29 | +2,15% | 4,49% | 38.082.434 |
| 26/06/2008 | 35,11 | 35,45 | 34,47 | 34,54 | -2,11% | 2,80% | 16.760.350 |
| 25/06/2008 | 35,07 | 35,50 | 34,67 | 35,29 | -0,13% | 2,37% | 23.204.292 |
| 24/06/2008 | 34,13 | 35,45 | 34,00 | 35,33 | +3,35% | 4,25% | 26.481.912 |
| 23/06/2008 | 33,60 | 34,34 | 33,51 | 34,19 | +1,99% | 2,47% | 19.792.947 |
| 20/06/2008 | 33,78 | 34,19 | 33,40 | 33,52 | -1,32% | 2,34% | 21.629.567 |
| 19/06/2008 | 33,23 | 34,42 | 33,19 | 33,97 | +2,12% | 3,70% | 28.315.178 |
| 18/06/2008 | 33,09 | 33,70 | 33,06 | 33,26 | +0,52% | 1,93% | 16.413.776 |
| 17/06/2008 | 33,51 | 33,79 | 33,05 | 33,09 | -0,94% | 2,19% | 15.808.451 |
| 16/06/2008 | 33,74 | 33,97 | 32,91 | 33,41 | -1,46% | 3,14% | 26.747.266 |
| 13/06/2008 | 34,02 | 34,32 | 33,32 | 33,90 | +0,37% | 2,95% | 20.006.215 |
| 12/06/2008 | 34,22 | 34,45 | 33,33 | 33,78 | -0,92% | 3,26% | 23.016.910 |
| 11/06/2008 | 34,83 | 34,95 | 33,81 | 34,09 | -1,81% | 3,29% | 27.080.530 |
| 10/06/2008 | 35,00 | 35,23 | 34,47 | 34,72 | -1,62% | 2,18% | 18.458.110 |
| 09/06/2008 | 35,88 | 36,10 | 35,03 | 35,30 | -1,33% | 2,98% | 15.823.438 |